New research shows application for Rna Diagnostic’s RDA™ in cancer development

By |May 15th, 2014|

TORONTO, Ontario –  The utility of Rna Diagnostics’ RDA™ (Rna Disruption Assay) test in assessing the effect of chemotherapy drugs has been further illustrated in research just published by Toronto biopharma company Armour Therapeutics. The study entitled, “Relaxin antagonist AT-001 synergizes with docetaxel in androgen-independent […]

Marketing Your Niche Business – Connected for Business

By |March 10th, 2014|

Some market niches are so narrow, you can count the number of potential customers. John Connolly of Rna Diagnostics figures there might be 30 Canadian cancer centres – and not more than 1,000 cancer centres worldwide – in a position to use his company’s diagnostic […]

Marketing Your Niche Business – Connected for Business

By |March 10th, 2014|

Some market niches are so narrow, you can count the number of potential customers. John Connolly of Rna Diagnostics figures there might be 30 Canadian cancer centres – and not more than 1,000 cancer centres worldwide – in a position to use his company’s diagnostic […]

Lessons learned from a small university seeking to commercialize a big discovery – University Affairs Newsletter

By |February 12th, 2014|

A Laurentian University lab has made a chance discovery that may lead to better breast cancer therapy.Read more

Sudbury researchers are poised to develop a new test that could help patients avoid chemotherapy – CTV Northern Ontario News at Noon

By |January 9th, 2014|

Sudbury researchers are poised to develop a new test that could help patients avoid chemotherapy. View clip

Breast cancer test developed in Sudbury shows promise

By |January 8th, 2014|

Research looks at which breast cancer patients will best respond to chemotherapy. A test developed in Sudbury may help doctors determine if chemotherapy will work for breast cancer patients. Read more

“Exciting” cancer test engineered in Sudbury – Sudbury Star

By |January 8th, 2014|

A test pioneered in Sudbury has already yielded promising results in a clinical trial and could play a pivotal role for patients undergoing breast cancer treatments if approved as a standard therapy tool. Read more

Sudbury researchers make cancer treatment breakthrough – Northern Life

By |January 8th, 2014|

A research team at Health Sciences North has developed a method that could see breast cancer treatments tailored to the particular genetic makeup of the patient.

The research is being called a potential breakthrough in chemotherapy because it allows physicians to see early on if a […]

New test developed in Sudbury promising for cancer patients – CBC Morning North (radio)

By |January 8th, 2014|

A clinical trial taking place in Sudbury could one day help doctors around the world determine if chemotherapy is the best treatment for cancer patients. We heard more about the trial from Dr. Amadeo Parissenti. Listen (runs 8:40)

Une équipe de Sudbury derrière ce test qui prédit les taux de survie au cancer – Radio-Canada

By |January 8th, 2014|

Une équipe de Sudbury derrière ce test qui prédit les taux de survie au cancer. Listen